sellModerate cluster of 2
KUPPUSAMY KARTHIK sold $279k of DGX
SVP, Clinical Solutions at QUEST DIAGNOSTICS INC. 1,775 shares at an average of $156.92, traded Oct 28, 2024, filed Oct 30, 2024.
Warning score
42Value
$279k
1,775 shares
Holdings after
9,734
-15% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001022079-24-000202, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 28, 2024 | SOpen-market sale Common Stock | -1,775 | $156.92 | $279k | 9,734 | Oct 30, 2024 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 23Weak | sell 210b5-1 | DGX QUEST DIAGNOSTICS INC | Doherty Catherine T. EVP, Regional Businesses | $5.4M | 33,103 | |
| 23Weak | sell 210b5-1 | DGX QUEST DIAGNOSTICS INC | PREVOZNIK MICHAEL E SVP & General Counsel | $5.7M | 35,146 | |
| 23Weak | sell 210b5-1 | DGX QUEST DIAGNOSTICS INC | DEPPE MICHAEL J SVP, Corp. Controller & CAO | $2.9M | 18,755 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.